SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-037852
Filing Date
2024-03-22
Accepted
2024-03-22 16:04:55
Documents
14
Period of Report
2024-03-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249580d1_8k.htm   iXBRL 8-K 22887
2 EXHIBIT 3.1 tm249580d1_ex3-1.htm EX-3.1 2891
  Complete submission text file 0001104659-24-037852.txt   202815

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pxmd-20240321.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pxmd-20240321_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pxmd-20240321_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT tm249580d1_8k_htm.xml XML 3833
Mailing Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 914-987-2876
PaxMedica, Inc. (Filer) CIK: 0001811623 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41475 | Film No.: 24775165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)